LGVN · Longeveron Inc.
$0.74
+0.04 (+6.06%)
At close · Aug 14
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has prepared a cash flow forecast which indicates that it does not have sufficient cash to meet its minimum expenditure commitments for one year from the date these financial statements are available to be issued and therefore needs to raise additional funds to continue as a going concern. As a result, there is substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$23.59M
Shares
31.88M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Wa’el Hashad | Former Chief Executive Officer | $1,281,252 |
| Paul Lehr | General Counsel and Corporate Secretary | $1,049,516 |
| Lisa Locklear | Chief Financial Officer and Treasurer | $862,087 |
| J. Nathaniel Powell | Former Interim Chief Executive Officer | $475,824 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Wa’el Hashad | Chief Executive Officer | $1,848,739 |
| Paul Lehr | General Counsel and Corporate Secretary | $1,226,696 |
| Lisa Locklear | Chief Financial Officer, Treasurer | $1,123,251 |
| J. Nathaniel Powell | Former Interim Chief Executive Officer | — |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Wa’el Hashad | Chief Executive Officer | $1,576,559 |
| Paul Lehr | General Counsel and Corporate Secretary | $554,055 |
| James Clavijo | — | $525,915 |
| Lisa Locklear | Chief Financial Officer, Treasurer | $380,779 |
| K. Chris Min | former interim CEO | $284,696 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| K. Chris Min | former interim CEO | $2,925,288 |
| Paul Lehr | General Counsel and Corporate Secretary | $983,158 |
| Former CFO | Treasurer | $774,558 |
| Geoff Green | — | $485,323 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Former CEO | — | $2,529,804 |
| Geoff Green | CEO | $2,529,804 |
| Paul Lehr | General Counsel and Corporate Secretary | $2,056,056 |
| James Clavijo | CFO, Treasurer | $1,589,929 |
| Joshua Hare | M.D., CSO, | $1,324,923 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Joshua Hare | M.D., CSO, | $270,000 |
| Geoff Green | CEO | $234,334 |
| Paul Lehr | International General Counsel and Corporate Secretary | $182,650 |
| James Clavijo | CFO, Treasurer | $171,806 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Arjun "JJ" Desai | Class III director | Appointed | 2026-07-06 |
| Marie Washburn | Senior Vice President and Chief Financial Officer | Appointed | 2026-07-06 |
| Lisa Locklear | Chief Financial Officer | Resigned | 2026-07-06 |
| Lisa Locklear | Chief Financial Officer | Resigned | 2026-06-05 |
| Roger Hajjar | Audit Committee member | Appointed | 2026-03-09 |
| Richard Kender | member of the Board of Directors | Resigned | 2026-03-09 |
| Stephen H. Willard | Chief Executive Officer | Appointed | 2026-02-13 |
| Than Powell | Interim Chief Executive Officer | Resigned | 2026-02-13 |
| Neha Motwani | Board of Directors | Resigned | 2025-11-12 |
| Khoso Baluch | Board of Directors | Resigned | 2025-11-12 |
| Dr. George Paletta | Class I director | Appointed | 2025-10-01 |
| Than Powell | interim Chief Executive Officer | Appointed | 2025-09-03 |
| Neil Hare | Board of Directors | Resigned | 2025-01-30 |
| Richard Kender | Class II director | Appointed | 2024-05-10 |
| Cathy Ross | Board | Resigned | 2024-05-10 |
| Jeffrey Pfeffer | Board of Directors | Resigned | 2024-05-10 |
| Lisa Locklear | Executive Vice President and Chief Financial Officer | Appointed | 2023-07-20 |
| Dr. Nataliya Agafonova M.D. | Chief Medical Officer ("CMO") | Appointed | 2023-07-05 |
| James Clavijo | Chief Financial Officer | Resigned | 2023-06-05 |
| James Clavijo | Chief Financial Officer | Resigned | 2023-04-10 |
| Wa'el Hashad | Board of Directors | Appointed | 2023-02-28 |
| Wa'el Hashad | Chief Executive Officer | Appointed | 2023-02-28 |
Key facts
CIK
1721484
CUSIP
54303L203
13F (30d)
36 filings
36 filers
Visit website
Investor relations